Generation of Antibodies to the Urokinase Receptor (uPAR) by DNA Immunization of uPAR Knockout Mice: Membrane‐Bound uPAR is Not Required for an Antibody Response

The urokinase receptor (uPAR) is a glycolipid‐anchored cell surface glycoprotein that plays a central role in extracellular proteolysis during tissue remodeling processes including cancer invasion. Furthermore, uPAR is found on the surface of both dendritic cells (DCs) and T cells, and has been proposed to play a role in DC‐induced T‐cell activation and, therefore, in the induction of an immune response. In order to investigate the possibility of using DNA immunization for the generation of poly‐ and monoclonal antibodies to uPAR, we injected wild‐type mice and mice deficient in uPAR (uPAR knockouts) intramuscularly with plasmid DNA encoding a carboxy‐terminal truncated soluble form of the human uPAR. Multiple injections of 100 µg of DNA resulted in a strong and specific antibody response in all mice irrespective of genotype. Antisera with a maximum titre of 32,000 were obtained, comparable with that obtained after immunization with recombinant uPAR. The subclass distribution of uPAR‐specific antibodies in the sera demonstrated the induction of a mixed TH1/TH2 response, irrespective of the genotype of the mice. Our results demonstrate the possibility of generating high titre antibodies to uPAR by DNA immunization of wild‐type as well as uPAR knockout mice, and that cell surface uPAR is not indispensable for the generation of a humoral immune response.

[1]  I. Pastan,et al.  Generation of high titer antisera in rabbits by DNA immunization. , 2001, Journal of immunological methods.

[2]  W. Kasinrerk,et al.  Production of polyclonal and monoclonal antibodies against CD54 molecules by intrasplenic immunization of plasmid DNA encoding CD54 protein. , 2001, Immunology letters.

[3]  N. Behrendt,et al.  Differential Binding of Urokinase and Peptide Antagonists to the Urokinase Receptor: Evidence from Characterization of the Receptor in Four Primate Species , 2001, Biological chemistry.

[4]  C. G. Black,et al.  Differences in epitope recognition, isotype and titer of antisera to Plasmodium falciparum merozoite surface protein 4 raised by different modes of DNA or protein immunization. , 2000, Vaccine.

[5]  B. Chain,et al.  Novel molecular mechanisms of dendritic cell-induced T cell activation. , 2000, International immunology.

[6]  R M Zinkernagel,et al.  Localization dose and time of antigens determine immune reactivity. , 2000, Seminars in immunology.

[7]  D. Drew,et al.  Humoral immune responses to DNA vaccines expressing secreted, membrane bound and non-secreted forms of the Tania ovis 45W antigen. , 2000, Vaccine.

[8]  H. Gårdsvoll,et al.  Generation of high-affinity rabbit polyclonal antibodies to the murine urokinase receptor using DNA immunization. , 2000, Journal of immunological methods.

[9]  A. Villa,et al.  uPA/uPAR System Is Active in Immature Dendritic Cells Derived from CD14+CD34+ Precursors and Is Down-Regulated upon Maturation1 , 2000, The Journal of Immunology.

[10]  M. Manthorpe,et al.  Adjuvants for plasmid DNA vaccines. , 2000, Methods in molecular medicine.

[11]  M. Ploug,et al.  Mapping Part of the Functional Epitope for Ligand Binding on the Receptor for Urokinase-type Plasminogen Activator by Site-directed Mutagenesis* , 1999, The Journal of Biological Chemistry.

[12]  D. Drew,et al.  Humoral responses in mice following vaccination with DNA encoding glutathione S‐transferase of Fasciola hepatica: effects of mode of vaccination and the cellular compartment of antigen expression , 1999, Parasite immunology.

[13]  E. Raz,et al.  Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences. , 1999, International Immunology.

[14]  R. Purcell,et al.  Route and Method of Delivery of DNA Vaccine Influence Immune Responses in Mice and Non-Human Primates , 1999, Molecular medicine.

[15]  Britton,et al.  Co‐immunization with DNA vaccines expressing granulocyte–macrophage colony‐stimulating factor and mycobacterial secreted proteins enhances T‐cell immunity, but not protective efficacy against Mycobacterium tuberculosis , 1999, Immunology.

[16]  R. Germain,et al.  Predominant Role for Directly Transfected Dendritic Cells in Antigen Presentation to CD8+ T Cells after Gene Gun Immunization , 1998, The Journal of experimental medicine.

[17]  R. Stephens,et al.  The urokinase receptor , 1998 .

[18]  R. Pardi,et al.  Through and beyond the wall: late steps in leukocyte transendothelial migration. , 1997, Immunology today.

[19]  A. Lew,et al.  Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. , 1997, International immunology.

[20]  J. Ulmer,et al.  Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes , 1997, Molecular medicine.

[21]  Simon C Watkins,et al.  DNA–based immunization by in vivo transfection of dendritic cells , 1996, Nature Medicine.

[22]  C. Walker,et al.  Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  E. Raz,et al.  Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization , 1996, Science.

[24]  K. Barnhart,et al.  An improved plasmid DNA expression vector for direct injection into skeletal muscle. , 1996, Human gene therapy.

[25]  R. Webster,et al.  DNA vaccines. , 1996, AIDS research and human retroviruses.

[26]  S. Mantegani,et al.  Ergoline Derivatives as a Probe for Featuring the 5-HT1A Receptor Pharmacophore , 1995 .

[27]  P. Declerck,et al.  Immunoassay of Murine t-PA, u-PA and PAI-1 Using Monoclonal Antibodies Raised in Gene-inactivated Mice , 1995, Thrombosis and Haemostasis.

[28]  K. Danø,et al.  The Receptor for Urokinase-type Plasminogen Activator Is Not Essential for Mouse Development or Fertility (*) , 1995, The Journal of Biological Chemistry.

[29]  G. Bishop,et al.  CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.

[30]  P. Carmeliet,et al.  Generation of monoclonal antibodies against autologous proteins in gene-inactivated mice , 1994 .

[31]  L. Pedersen,et al.  Antibodies Directed Against Monomorphic and Evolutionary Conserved Self Epitopes may be Generated in ‘Knock‐Out’ Mice. Development of Monoclonal Antibodies Directed Against Monomorphic MHC Class I Determinants , 1994, Scandinavian journal of immunology.

[32]  S. Johnston,et al.  Production of monoclonal antibodies by genetic immunization. , 1994, BioTechniques.

[33]  H. V. Herck,et al.  Recommendations for the health monitoring of mouse, rat, hamster, guineapig and rabbit breeding colonies: Report of the Federation of European Laboratory Animal Science Associations (FELASA) Working Group on Animal Health accepted by the FELASA Board of Management November 1992 , 1994, Laboratory animals.

[34]  M. Ploug,et al.  Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator. , 1992, European journal of biochemistry.

[35]  D. Tang,et al.  Genetic immunization is a simple method for eliciting an immune response , 1992, Nature.

[36]  F. Blasi,et al.  Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract , 1991, The Journal of cell biology.

[37]  M. Ploug,et al.  Cell‐induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2‐terminal domain of the urokinase receptor , 1991, FEBS letters.

[38]  E. Appella,et al.  Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. , 1990, The EMBO journal.